Ticker League

Current

36.2×

As of May 10, 2023

5-Year Average

31.0×

All-Time High

2367.9×

Dec 31, 2010

All-Time Low

4.5×

May 11, 2022

P/S Ratio daily chart for SELLAS Life Sciences Group (SLS)

Jun 14, 2021 – Jun 12, 2026 · 1,256 trading days

P/S ratio is not shown for periods when TTM revenue was negative.

Historical P/S Ratio for SELLAS Life Sciences Group (SLS) from 2007 to 2025

  • 2025
  • 2024
  • 2023
  • 202249.1×
  • 202111.6×
  • 202031.8×
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014179.2×
  • 20132086.1×
  • 2012556.0×
  • 2011
  • 20102367.9×
  • 2009
  • 2008
  • 2007

About P/S Ratio at SELLAS Life Sciences Group (SLS)

SELLAS Life Sciences Group (SLS) P/S ratio is 36.2× as of May 10, 2023. The 5-year average is 31.0×. The sector median currently stands at 3.7×. The current ratio is at the 71th percentile of its own 10-year history.

SELLAS Life Sciences Group (SLS) historical P/S ratio has ranged from a low of 4.5× (2022) to a high of 2367.9× (2010) in the available daily series.

The price-to-sales (P/S) ratio compares a company's market capitalisation to its trailing twelve-month (TTM) revenue. It is calculated as market cap ÷ TTM revenue (equivalent to share price ÷ TTM revenue per share). Because the denominator (revenue) cannot be negative, P/S is widely used to value unprofitable or pre-profit companies and to make cross-sector comparisons.

SELLAS Life Sciences Group P/S Ratio by Year

SELLAS Life Sciences Group P/S Ratio 2022: 49.1×

SELLAS Life Sciences Group (SLS) P/S ratio in 2022 was 49.1×, expanded from 11.6× the prior year.

SELLAS Life Sciences Group P/S Ratio 2021: 11.6×

SELLAS Life Sciences Group (SLS) P/S ratio in 2021 was 11.6×, contracted from 31.8× the prior year.

SELLAS Life Sciences Group P/S Ratio 2020: 31.8×

SELLAS Life Sciences Group (SLS) P/S ratio in 2020 was 31.8×, contracted from 179.2× the prior year.

SELLAS Life Sciences Group P/S Ratio 2014: 179.2×

SELLAS Life Sciences Group (SLS) P/S ratio in 2014 was 179.2×, contracted from 2086.1× the prior year.

SELLAS Life Sciences Group P/S Ratio 2013: 2086.1×

SELLAS Life Sciences Group (SLS) P/S ratio in 2013 was 2086.1×.

Sector peers by P/S Ratio — chart

Current ratio vs. sector peers. Highlighted bar is this company.

Frequently asked questions